Alimera Sciences Inc. (ALIM)
NASDAQ: ALIM
· Real-Time Price · USD
5.54
-0.01 (-0.18%)
At close: Sep 13, 2024, 10:00 PM
Alimera Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 27M | 23.01M | 26.31M | 23.36M | 17.54M | 13.55M | 14.03M | 13.6M | 14.6M | 11.9M | 13.96M | 12.15M | 21.7M | 11.21M |
Cost of Revenue | 3.83M | 3.35M | 3.63M | 2.76M | 2.42M | 2.03M | 2.13M | 2.01M | 2.17M | 1.68M | 1.97M | 1.69M | 1.81M | 1.56M |
Gross Profit | 23.17M | 16.57M | 22.68M | 17.45M | 15.11M | 11.52M | 11.9M | 11.59M | 12.44M | 10.22M | 11.99M | 10.46M | 19.89M | 9.65M |
Operating Income | -77K | -2.3M | 724K | 1.85M | -1.21M | -3.3M | -2.11M | -3.41M | -1.97M | -4.15M | -2.75M | -2.02M | 7M | -2.43M |
Interest Income | n/a | n/a | n/a | n/a | 1.69M | 1.67M | n/a | 1.5M | 1.38M | 1.36M | n/a | n/a | n/a | n/a |
Pretax Income | -3.35M | -6.28M | -3.77M | -1.3M | -10M | -4.97M | -3.78M | -5.25M | -3.1M | -5.96M | -4.14M | -4.35M | 8.21M | -3.65M |
Net Income | -3.31M | -6.25M | -3.78M | -1.35M | -10.03M | -4.97M | -3.78M | -5.26M | -3.12M | -5.96M | -4.11M | -4.18M | 7.57M | -3.65M |
Selling & General & Admin | 15.88M | 14.51M | 14.15M | 11.55M | 10.81M | 9.97M | 9.1M | 9.86M | 9.81M | 10.09M | 10.37M | 8.56M | 8.69M | 8.23M |
Research & Development | 4.26M | 4.36M | 4.77M | 4.04M | 3.65M | 4.16M | 4.23M | 4.48M | 3.93M | 3.58M | 3.72M | 3.28M | 3.57M | 3.21M |
Other Expenses | n/a | 3.08M | -1.08M | 402K | n/a | 681K | 683K | 664K | 670K | 689K | 659K | 649K | 633K | 638K |
Operating Expenses | 20.14M | 21.96M | 18.45M | 15.99M | 16.32M | 14.82M | 14.01M | 15M | 14.41M | 14.37M | 14.74M | 12.49M | 12.89M | 12.08M |
Interest Expense | 3.15M | 3.74M | 4.75M | 2.07M | 1.69M | 1.67M | 1.63M | 1.5M | 1.38M | 1.36M | 1.36M | 1.36M | 1.35M | 1.34M |
Selling & Marketing Expenses | 8.51M | 9.08M | 7.77M | 7.94M | 6.43M | 5.8M | 5.76M | 6.5M | 6.87M | 6.85M | 7.17M | 5.75M | 5.33M | 4.82M |
Cost & Expenses | 27.06M | 25.14M | 25.12M | 18.75M | 18.75M | 16.85M | 16.14M | 17.01M | 16.58M | 16.05M | 16.71M | 14.18M | 14.7M | 13.64M |
Income Tax Expense | -43K | -32K | 7K | 53K | 25K | n/a | -1K | 12K | 17K | n/a | -33K | -169K | 640K | n/a |
Shares Outstanding (Basic) | 54.38M | 54.36M | 54.42M | 32.11M | 8.09M | 7.03M | 7M | 7M | 7M | 6.99M | 6.92M | 6.92M | 7.35M | 5.75M |
Shares Outstanding (Diluted) | 54.38M | 54.36M | 54.42M | 32.11M | 8.09M | 7.03M | 7M | 7M | 7M | 6.99M | 6.93M | 6.92M | 7.36M | 5.75M |
EPS (Basic) | -0.06 | -0.11 | -0.07 | -0.04 | -1.24 | -1.18 | -0.54 | -0.75 | -0.45 | -0.85 | -0.59 | -0.6 | 1.03 | -0.63 |
EPS (Diluted) | -0.06 | -0.11 | -0.07 | -0.04 | -1.24 | -1.18 | -0.54 | -0.75 | -0.45 | -0.85 | -0.59 | -0.6 | 1.03 | -0.63 |
EBITDA | 2.89M | 541K | 4.02M | 3.93M | 658K | -2.62M | -1.46M | -2.75M | -1.3M | -3.46M | -2.09M | -1.37M | 7.64M | -1.79M |
EBIT | -201K | -2.54M | 980K | 769K | -8.31M | -3.3M | -2.15M | -3.75M | -1.72M | -4.59M | -2.78M | -2.99M | 9.55M | -2.31M |
Depreciation & Amortization | 3.09M | 3.08M | 3.04M | 3.16M | 1.87M | 681K | 683K | 664K | 670K | 689K | 659K | 649K | 633K | 638K |